Vaccine safety check: tracking infant reactions in routine shots
NCT ID NCT06793826
Summary
This study monitored the safety of the Hexaxim vaccine, which protects against six diseases including hepatitis B and Hib, after it was given to infants as part of routine care in South Korea. Researchers tracked over 700 infants for about 5-6 weeks after vaccination to record any side effects, from common reactions like tenderness or fussiness to more serious events. The goal was to understand the real-world safety profile of this combination vaccine when used in standard medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 001
Seoul, South Korea
-
Investigational Site Number : 002
Cheonan, South Korea
Conditions
Explore the condition pages connected to this study.